COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804


Print ISSN:-2393-9079

Online ISSN:-2393-9087

CODEN : IJPPTK

Current Issue

Year 2020

Volume: 7 , Issue: 1

Article Access statistics

Viewed: 631

Emailed: 0

PDF Downloaded: 222

Indian Journal of Pharmacy and Pharmacology


Cardioprotective and antihyperglycemic activity of vildagliptin in presence of nifedipine on adrenaline induced hyperglycemic rat


Full Text PDF Share on Facebook Share on Twitter


Author Details : Saraswati Prasad Mishra, Suruchi Samparna Acharya, Pankaj Kashyap, Deepak Kumar Dash, Koushlesh Mish

Volume : 4, Issue : 3, Year : 2017

Article Page : 134-137


Suggest article by email


Abstract

Generally there is higher prevalence of co-morbidity of diabetes and hypertension. Mortality increases more than 7 times when patient is having diabetes along with hypertension. In India 6.4% to 55% prevalence of hypertension among diabetes (Type 2) patients was found. Vildagliptin is an oral anti hyperglycemic agent of new class dipeptidyl peptidase-4 (DPP-4) inhibitor. Nifedipine is an antihypertensive drug that comes under the class of calcium channel blockers. The present study is to find out the effect of co administration of Nifedipine and Vildagliptin on cardioprotective and antihyperglycemic activity in adrenaline induced hyperglycemic rats. In acute and chronic condition study glucose level and lactate dehydrogenase (LDH) estimation in blood was done with the help of Glucometer and Lactate dehydrogenase assay kit respectively. Albino Rats heart muscles were subjected to histopathological examination. After co-administration of drugs initial glucose level (142.77 ± 12.9 mg/dl) and final blood glucose level (135.1 ± 48.7 mg/dl) in acute condition and initial glucose level (160.2 ± 9.3 mg/dl) and final blood glucose level (154.6 ±14.8 mg/dl) in chronic condition were found. In chronic condition initial LDH level (455.9 ±17.1 IU/L) and final LDH level (236 ±24.1 IU/L) in blood were found. In microscopic examination of endocardium layer of adrenaline induced hyperglycemic rats treated with co-administration of drugs necrosis was not found, it confirms their cardioprotective activity. On the basis of study conclusion was that when co-administration of Nifedipine and Vildagliptin, nifedipine significantly reducing the antihyperglycemic activity but it has no markedly effect on cardioprotective activity.

Keywords:
Vildagliptin, Nifedipine, Lactate dehydrogenase, Dipeptidyl peptidase-4 inhibitor

How to cite : Mishra S P, Acharya S S, Kashyap P, Dash D K, Mish K, Cardioprotective and antihyperglycemic activity of vildagliptin in presence of nifedipine on adrenaline induced hyperglycemic rat. Indian J Pharm Pharmacol 2017;4(3):134-137

Copyright © 2017 by author(s) and Indian J Pharm Pharmacol. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (creativecommons.org)